Journals / Eskisehir Medical Journal / 2022 / Cilt: 3 - Sayı: 1

The Effects of Type 2 Diabetes Mellitus Patients on The HbA1c Levels of Self-Monitoring And Drug Barriers

Tip 2 Diyabet Mellitus Hastalarının Yaşadığı Kendini İzleme ve İlaç Engellerinin HbA1c Düzeylerine Etkisi

Pages
53–63
Publication Date
2022-03-12
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

It was observed that the F value (F = 8.599 p = 0.000) related to the validity of the established regression model was also significant (p <0.05).Conclusion: It was found that there was a moderate relationship between the HbA1c levels of the patients and the drug barrier scale score and self-monitoring barrier scale score variables.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Introduction: Much evidence indicates that diabetes is a progressive disease and that complex treatment algorithms require ongoing, tailored, and protocol-based medical care that includes patient self-management and education.
📊
Key Findings & Data:The study, it was aimed to investigate the relationship the self monitoring obstaclelevels of patients with Type 2 Diabetes to their HbA1c levels.Methods: The sample of the descriptive and cross-sectional study consisted of 332 patients with Type 2 diabetes who applied to the endocrinology outpatient clinic of a private hospital.
💡
Conclusion & Impact:It was observed that the F value (F = 8.599 p = 0.000) related to the validity of the established regression model was also significant (p <0.05).Conclusion: It was found that there was a moderate relationship between the HbA1c levels of the patients and the drug barrier scale score and self-monitoring barrier scale score variables.
🔬Design:Survey & Empirical Study
📍Scope:Comprehensive Sample
⚙️Variables:Tip 2 diyabet · kendini izleme · HbA1c

Abstract

Introduction: Much evidence indicates that diabetes is a progressive disease and that complex treatment algorithms require ongoing, tailored, and protocol-based medical care that includes patient self-management and education. The study, it was aimed to investigate the relationship the self monitoring obstaclelevels of patients with Type 2 Diabetes to their HbA1c levels.Methods: The sample of the descriptive and cross-sectional study consisted of 332 patients with Type 2 diabetes who applied to the endocrinology outpatient clinic of a private hospital. The data of the study were collected Personal Information Form, Self-Monitoring Barriers and Drug Barriers Scale, which are the "The Diabetes Obstacles Questionnaire (DOQ)".Results: According to the regression model established, it was determined that HbA1c affected the age (p=0.001), duration of diagnosis (p=0.013) and the size of drug barriers (p=0.028) and explained it by 12%. It was determined that these independent variables do not have auto correlation, that is, they do not affect each other. It was observed that the F value (F = 8.599 p = 0.000) related to the validity of the established regression model was also significant (p <0.05).Conclusion: It was found that there was a moderate relationship between the HbA1c levels of the patients and the drug barrier scale score and self-monitoring barrier scale score variables. To achieve successful results in the treatment of patients with type 2 diabetes; the obstacles experienced by the patients should be identified and treatment should be planned according to the needs of the patients and patient-centered education should be provided.

Özet

Giriş: Birçok kanıt, diyabetin ilerleyici bir hastalık olduğunu ve karmaşık tedavi algoritmalarının hastanın kendi kendine yönetimini ve eğitimini içeren sürekli, özel ve protokole dayalı tıbbi bakım gerektirdiğini göstermektedir. Araştırma, Tip 2 diyabetli hastaların kendini izleme engellerinin tedavinin başarıya ulaştığının en önemli göstergesi olan HbA1c seviyesine etkisini incelemek amacıyla yapılmıştır.Yöntemler: Tanımlayıcı ve kesitsel nitelikteki çalışmanın örneklemini özel bir hastanenin endokrinoloji polikliniğine başvuran Tip 2 diyabetli 332 hasta oluşturmuştur. Araştırma verileri, demografik değişkenlerin sorgulandığı Kişisel Bilgi Formu, Tip 2 Diyabet hastalarında Diyabette Engeller Ölçeğinin Kendini İzleme Engelleri ve İlaç Engelleri ile toplanmıştır.Bulgular: HbA1c’nin yaş (p=0,001), tanı süresi (p=0,013) ve ilaç engelleri boyutunu (p=0,028) etkilediği ve %12 oranında açıkladığı belirlenmiştir. Bu bağımsız değişkenlerin oto korelasyonun olmadığı yani bir birbirlerini etkilemediği belirlenmiştir. Regresyon modelinin geçerliliğine ilişkin F değerinin de (F=8.599 p=0.000) anlamlı olduğu gözlenmiştir (p<0.05).Sonuç: Hastaların HbA1c düzeyleri ile ilaç engelleri ölçek puanı ve kendini izleme engelleri ölçek puanı değişkenleri arasında orta düzeyde bir ilişki olduğu belirlenmiştir. Tip 2 diyabetli hastaların tedavisinde başarılı sonuçlara ulaşmak için; hastaların yaşadıkları engeller belirlenmeli ve hastaların ihtiyaçlarına göre tedavi planlanmalı, hasta merkezli eğitim verilmelidir.

🔖

Cite This Article

TÜRE, A., DEMİRSOY, N., GÖDEK, Ö. (2022). The Effects of Type 2 Diabetes Mellitus Patients on The HbA1c Levels of Self-Monitoring And Drug Barriers. Eskisehir Medical Journal, Cilt: 3 - Sayı: 1, 53–63. https://ajindex.com/articles/851809

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. International Diabetes Federation.(2019). Diabetes Atlas,9.ed. Available at https://www.diabetesatlas.org/en/sections/worldwide-toll-of-diabetes.html 2-
  2. WHO (2013). 10 Facts about Diabetes. http://www.who.int/features/factfiles/ diabetes/en/index.html. 2013
  3. International Diabetes Federation.(2017). Guideline on self-monitoring of blood glucose in non-insulin treated type 2 diabetes. Available at
  4. Chatterjee S, Khunti., Davies M.J.(2017). Type 2 diabetes. The Lancet, 389(10085) 2239-2251.
  5. Zhuo X, Zhang P, Barker L, et al.(2014). The lifetime cost of diabetes and its implications for diabetes prevention. Diabetes Care, 37(9),2557-64. doi:10.2337/dc13-2484.
  6. Wu Y, Goldman, D. P. (2016). Impact of type 2 diabetes medication cost sharing on patient outcomes and health plan costs. Am J Manag Care, 22(6), 433-440
  7. Nakao, M, Hara Y, Ishihara Y.(2016). Psychological impacts from expectation ofworsening conditions and obstacles to life planning are affected by glycemic control, self-reported symptoms, and drug therapy in patients with type 2 diabetes mellitus. J Diabetes Investig, 7, 420–428.
  8. Schnell O, Hanefeld M, Monnier L.(2014). Self-monitoring of blood glucose: a prerequisite for diabetes management in outcome trials. Journal of Diabetes Science and Technology, 8(3), 609-614
  9. Guo J, Long Q, Li J, et al. (2020). Barriers and facilitators of self-monitoring of blood glucose engagement among women with gestational diabetes mellitus in China: A mixed-methods study. Midwifery, 90, 102797
  10. Ong W.M, Chua S.S, Ng C.J.(2014). Barriers and facilitators to self-monitoring of blood glucose in people with type 2 diabetes using insulin: a qualitative study. Patient Preference and Adherence, 8,237.
  11. Higgins T.(2013). HbA1c for screening and diagnosis of diabetes mellitus. Endocrine, 43(2),266e73.
  12. Stratton I.M, Adler A.I, Neil H.A.W, et al.(2000). Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ, 321(7258),405-412.
  13. Diyabet Tanı ve Tedavi